E-DRUG: Reminder: webinar Dec 13: Addressing high drug prices: what can be learned from European policies?
--------------------------------------------------------------------------------------------
Dear all,
this is a gentle reminder that the next webinar organized by the
Knowledge Network on Innovation and Access to Medicines, will take place
Today (Dec 13). Please see below for more information and registration
link.
Addressing high drug prices: what can be learned from European policies?
<http://graduateinstitute.ch/contents/events/globalhealth/webinar-addressing-high-drug-pri.html>
Thursday 13 December | 4:00pm-5:00pm CET
Speaker:
Sabine Vogler is head of the Pharmacoeconomics Department and head of the
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement
Policies at the Austrian Public Health Institute (GÖG).
Paper:
Ensuring access to medicines: How to redesign pricing, reimbursement and> procurement?
Background
Drug prices are high on the political agenda of countries worldwide.
Rising prices of new medicines can restrict patient access and threaten the
sustainability of health systems. Many countries are currently debating the
adoption or reform of policies to better manage medicines prices. What can
be learned from Europe, the region that has arguably had the most extensive
experience with pricing policies?
Dr. Vogler will present a recently published paper analysing evidence
related to a range of policy options used by European Union countries
related to pricing, procurement and reimbursement of medicines, including
generic drugs and biosimilars. She will describe the most commonly-used
policies, explain the benefits and limitations of each, and offer proposals
for how to improve them. She will also explore more far-reaching measures
that can fundamentally tackle the issue of high medicines prices.
Who should consider attending?
Those interested in learning more about:
- Access to medicines and sustainability of health systems;
- Policy instruments to address high drug prices, including purchase ofgenerics and biosimilars;
- Collaborative efforts to reduce prices, such as joint price negotiations
and pooled procurement;
- Transparency of medicines prices and R&D costs
What should you expect to hear?
- An overview of policies used by European Union countries to regulate
prices and determine the reimbursement of medicines;
- Advantages and limitations of each policy instrument, including external
price referencing (EPR), managed entry agreements (MEA), health technology
assessment (HTA) and tendering, and options to improve them;
- Further interventions to complement the policies options currently used.<https://zoom.us/webinar/register/4815438597371/WN_M2PqnnqRROqzdmL6iTTnZA>
Participants will be able to pose questions orally and in writing during
the webinar, and the speaker will respond to a selection of these during
the second half of the event. Recordings of all webinars will be made
a a confirmation email with additional information on how to join the webinar.
We hope you will be able to join us for this informative presentation.
This event is part of the inaugural webinar series of the Knowledge Network
for Innovation and Access to Medicines, a project of the Global Health
Centre at the Graduate Institute of Geneva. Suggestions for speakers and
topics for future webinars are welcome at
globalhealthresearch@graduateinstitute.ch.
-
Marcela Vieira
Project Coordinator
Knowledge Network for Innovation and Access to Medicines> Global Health Centre, Research
marcela.vieira@graduateinstitute.ch